Back

Development and validation of a novel bleeding risk score during direct oral anticoagulant therapy in patients with cancer-associated venous thromboembolism

29 August 2026 (11:15 - 11:45)
Organised by: Logo
Congress Presentation Part of: Managing and improving safety in antithrombotic pharmacotherapy Anticoagulants ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Tomoyuki Nagai

Kyoto Prefectural University of Medicine, Kyoto (Japan)

2 More presentations in this session

Presentation thumbnail
Oral anticoagulation monotherapy versus dual antithrombotic therapy in chronic coronary syndrome patients requiring long-term anticoagulation: a bayesian meta-analysis of randomised controlled trials
Doctor B. Rodriguez-Tapia (Trujillo, PE)
Abstract Slides Video
Presentation thumbnail
Intraoperative antithrombotic drug removal during urgent CABG: early German experience with a novel hemoadsorption device
Professor U. Zeymer (Ludwigshafen, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Managing and improving safety in antithrombotic pharmacotherapy

The Event

Event poster

ESC Congress 2026

29 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Application of DOAC Score for the risk-stratification of major bleeding in patients with venous thromboembolism on direct oral anticoagulants: insight from the COMMAND VTE Registry-2
2 September 2024
thumbnail
Congress Session
Personalising antithrombotic therapy in patients with cancer: what every cardiologist should know
31 August 2024
thumbnail
Congress Presentation
Direct oral anticoagulants-associated bleeding complications in patients with genitourinary cancer and venous thromboembolism: from the COMMAND VTE Registry-2
30 August 2026
thumbnail
Congress Presentation
Practical value and external validation of the PRECISE-DAPT cancer score in patients with acute myocardial infarction
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources